Friday, January 28, 2022

 

Biologics and Biosimilars: FDA Initiatives and Guidance, Approvals and Exclusivity, Patent Prosecution, Litigation
Date: February 16, 2022
Venue: Interactive virtual event

No comments:

Post a Comment